Since 1994, Abbott has been at the forefront of viral surveillance, with an unwavering commitment to monitor emerging and changing infectious diseases. As the only provider of infectious disease solutions with this large-scale Global Viral Surveillance Program, our mission is driven by two guiding principles:

• Keeping pace with viral sequence heterogeneity and emerging strains in human populations
• Enabling our tests to help detect diverse HIV and hepatitis strains regardless of where they evolve¹

Take a look at some of our recent publications that reveal unique insights into local epidemiologies and highlight some of our discoveries. See how the work of the Abbott Global Viral Surveillance Program plays a significant role in challenging our on-market tests and looks ahead for new challenges with innovative research tools.

Abbott researchers work with cutting edge technologies and collaborate with leading hospitals and organizations worldwide to test diverse specimens that carry viruses that may cause deadly diseases. In fact, Abbott is only 1 of 2 institutions in the world to have identified and characterized rare HIV Group N and P viruses.^1,6,8

Abbott partners with laboratories and organizations in 45 countries around the world, represented by the yellow triangles on the map below. The red triangles denote Abbott Global Surveillance sites.

Decades of global surveillance research and ongoing vigilance consistently fuel Abbott’s next generation of infectious disease solutions

1. Brennan CA, et al. HIV global surveillance: Foundation for retroviral discovery and assay development. Journal of Medical Virology. 2006; 78:S24-S29. 
2. Pyne MT. et al. Large-scale analysis of the prevalence and geographic distribution of HIV_-1 non-B variants in the United States. J. Clin. Microbiol. 2013; 51, 2662–2669. 
3. Berg MG, et al. Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection. PLoS Pathogens. 2015 Dec 11; 11(12):e1005325. 
4. Data on File at Abbott. 
5. Vallari, A. et al. Confirmation of putative HIV_-1 group P in Cameroon. J. Virology 2011 Feb; 85:1403-1407. 
6. Rodgers MA, et al. Identification of rare HIV_-1 Group N, HBV AE, and HTLV_-3 strains in rural South Cameroon. Virology. 2017 Apr; 504:141-151.
7. Yamaguchi J, et al. Complete genome sequence of CG-0018a-01 establishes HIV_-1 subtype L. Journal of Acquired Immune Deficiency Syndromes: November 06, 2019.
8. Rodgers M, Wilkinson E, Vallari A, et al. Sensitive next-generation sequencing method reveals deep genetic diversity of HIV_-1 in the Democratic Republic of the Congo. Journal of Virology. 2017; 91: e01841-16.